Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Osmogreen
- Development stage
- Unknown
- Lead developer
- Akrovis
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Osmogreen is an oral multivitamin and multimineral nutritional supplement developed and marketed by Akrovis. Formulated as a tablet, it is designed to address nutritional deficiencies, boost energy levels, support immune function, and combat oxidative stress. The supplement provides a combination of essential vitamins, minerals, and antioxidants to bridge dietary gaps, enhance metabolic processes, and promote overall physical and mental well-being.
- Brand names
- Osmogreen
- Other names
- Osmogreen TabOsmogreen Tablet
Beyond the preview
Go deeper on Osmogreen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Osmogreen.